{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:38:32Z","timestamp":1722991112354},"reference-count":11,"publisher":"American Society of Consultant Pharmacists","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["sr care pharm"],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:p><jats:bold>Background<\/jats:bold> The Southern Arizona VA Health Care System (SAVAHCS) implemented a delirium prevention and treatment protocol in 2019.  <jats:bold>Objective<\/jats:bold> The primary objective of this study was to determine if the implementation of a delirium protocol influenced deliriogenic\n medication use in hospitalized geriatric veterans. The secondary objectives were to compare the rates of delirium diagnosis, hospital length-of-stay, and rates of newly started deliriogenic medications during admission pre- and post-protocol.  <jats:bold>Methods<\/jats:bold> This study was a retrospective,\n secondary data analysis study. Veterans 65 years of age and older who were admitted to an inpatient medical ward at the SAVAHCS for 24 hours or more between January 1, 2018 and December 31, 2018 (pre-protocol) or January 1, 2021 and December 31, 2021 (post-protocol) were included. Patients\n were excluded if they had a diagnosis of alcohol or benzodiazepine withdrawal upon admission.  <jats:bold>Results<\/jats:bold> A total of 5491 patients were included in this study; 2940 (53.5%) in the pre-protocol group and 2551 (46.5%) in the post-protocol group. Patients received at least one\n deliriogenic medication during their admission in the post-protocol group (36.2%) compared with the pre-protocol group (34.1%), but there was no statistically significant difference (<jats:italic>P<\/jats:italic> = 0.098). There were also no significant differences in the rates of documentation of delirium as\n a diagnosis at discharge, hospital length-of-stay, or the rates of newly started deliriogenic medications during admission between the groups.  <jats:bold>Conclusion<\/jats:bold> Implementation of a delirium prevention and treatment protocol at the SAVAHCS did not significantly impact the use of\n deliriogenic medications in hospitalized geriatric veterans.<\/jats:p>","DOI":"10.4140\/tcp.n.2024.291","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T08:00:52Z","timestamp":1722412852000},"page":"291-299","source":"Crossref","is-referenced-by-count":0,"title":["Impact of a Delirium Protocol on Deliriogenic Medication Use in Hospitalized Older Veterans"],"prefix":"10.4140","volume":"39","author":[{"given":"Alison M.","family":"Weygint","sequence":"first","affiliation":[{"name":"Southern Arizona VA Health Care System, Pharmacy Service, Tucson, Arizona."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"LaMarr","sequence":"additional","affiliation":[{"name":"Southern Arizona VA Health Care System, Pharmacy Service, Tucson, Arizona."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Lee","sequence":"additional","affiliation":[{"name":"Southern Arizona VA Health Care System, Pharmacy Service, Tucson, Arizona."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","reference":[{"issue":"15","key":"ref1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMcp1605501","article-title":"Delirium in hospitalized older adults. In: Solomon CG, ed.","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"ref2","first-page":"674","article-title":"2019 American Geriatrics Society Beers Criteria\u00ae Updated Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults: 2019 AGS Beers Criteria\u00ae Updated Expert Panel","volume":"67","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jagp.2018.06.007","article-title":"Hospital elder life program: systematic review and meta-analysis of effectiveness","volume":"26","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"journal-title":"Proactive Inter-Profession Delirium Prevention: Findings and Learnings from Pilots. Kaiser Foundation Health Plan. Presented at: American Delirium Society","year":"2018","key":"ref4"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ccc.2017.03.013","article-title":"Acute brain failure: pathophysiology, diagnosis, management, and sequelae of delirium","volume":"33","year":"2017","journal-title":"Crit Care Clin"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199903043400901","article-title":"A multicomponent intervention to prevent delirium in hospitalized older patients","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1532-5415.2001.49108.x","article-title":"Reducing delirium after hip fracture: a randomized trial","volume":"49","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/jgs.15781","article-title":"Pharmacological management of delirium in the intensive care unit: a randomized pragmatic clinical trial","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4140\/TCP.n.2023.21","article-title":"Deliriogenic medication prescribing and delirium in hospitalized, non-critically ill older people","volume":"38","year":"2023","journal-title":"Sr Care Pharm"},{"journal-title":"J Am Geriatr Soc","article-title":"2023 American Geriatrics Society Beers Criteria\u00ae Updated Expert Panel. American Geriatrics Society 2023 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","year":"2023","key":"ref10"},{"volume-title":"Antipsychotics for the Prevention and Treatment of Delirium","year":"2019","key":"ref11"}],"container-title":["The Senior Care Pharmacist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ascp\/tscp\/2024\/00000039\/00000008\/art00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T08:35:03Z","timestamp":1722933303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.4140\/TCP.n.2024.291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"alternative-id":["2639-9636(20240801)39:8L.291;1-"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2024.291","relation":{},"ISSN":["2639-9636"],"issn-type":[{"type":"print","value":"2639-9636"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}